3-42210085-CGGAGGAGGAGGAGGA-CGGAGGAGGAGGAGGAGGAGGA
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP3BP6_ModerateBA1
The NM_001265608.2(TRAK1):c.2090_2095dupAGGAGG(p.Glu697_Glu698dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.30 ( 7034 hom., cov: 0)
Exomes 𝑓: 0.26 ( 6905 hom. )
Consequence
TRAK1
NM_001265608.2 disruptive_inframe_insertion
NM_001265608.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.622
Genes affected
TRAK1 (HGNC:29947): (trafficking kinesin protein 1) Predicted to enable GABA receptor binding activity and myosin binding activity. Involved in endosome to lysosome transport. Located in early endosome and mitochondrion. Implicated in developmental and epileptic encephalopathy 68. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001265608.2
BP6
Variant 3-42210085-C-CGGAGGA is Benign according to our data. Variant chr3-42210085-C-CGGAGGA is described in ClinVar as [Benign]. Clinvar id is 977317.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.302 AC: 44489AN: 147150Hom.: 7029 Cov.: 0
GnomAD3 genomes
AF:
AC:
44489
AN:
147150
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.253 AC: 47873AN: 189446Hom.: 1448 AF XY: 0.246 AC XY: 25246AN XY: 102570
GnomAD3 exomes
AF:
AC:
47873
AN:
189446
Hom.:
AF XY:
AC XY:
25246
AN XY:
102570
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.258 AC: 367960AN: 1426146Hom.: 6905 Cov.: 0 AF XY: 0.258 AC XY: 182340AN XY: 708046
GnomAD4 exome
AF:
AC:
367960
AN:
1426146
Hom.:
Cov.:
0
AF XY:
AC XY:
182340
AN XY:
708046
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.302 AC: 44519AN: 147242Hom.: 7034 Cov.: 0 AF XY: 0.306 AC XY: 21844AN XY: 71480
GnomAD4 genome
AF:
AC:
44519
AN:
147242
Hom.:
Cov.:
0
AF XY:
AC XY:
21844
AN XY:
71480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 68 Uncertain:1Benign:1
Jan 23, 2024
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Myelin Disorders Clinic-Children's Medical Center/Medical Genetics Lab-Tarbiat Modares University, Children's Medical Center, Pediatrics Center of Excellence,
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at